Allergan - 26 Year Stock Price History | AGN

Historical daily share price chart and data for Allergan since 1993 adjusted for splits. The latest closing stock price for Allergan as of December 13, 2019 is 188.34.
  • The all-time high Allergan stock closing price was 339.50 on July 28, 2015.
  • The Allergan 52-week high stock price is 190.41, which is 1.1% above the current share price.
  • The Allergan 52-week low stock price is 114.27, which is 39.3% below the current share price.
  • The average Allergan stock price for the last 52 weeks is 154.59.
Allergan Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 155.3560 135.8800 188.3400 115.7300 188.3400 40.91%
2018 168.9550 170.3200 193.4600 129.8200 133.6600 -18.29%
2017 219.9149 216.1900 256.1500 163.5800 163.5800 -22.11%
2016 241.6986 307.4700 308.7300 188.4700 210.0100 -32.80%
2015 297.2026 259.1300 339.5000 252.1000 312.5000 21.40%
2014 220.0415 168.0500 270.6100 167.9300 257.4100 53.22%
2013 122.9644 84.2100 168.0000 83.1000 168.0000 95.35%
2012 74.4166 60.6300 90.8500 55.8900 86.0000 42.53%
2011 62.3179 51.4900 72.1000 50.5900 60.3400 16.82%
2010 43.6171 40.2900 51.9500 37.6900 51.6500 30.40%
2009 32.4724 26.3000 40.1200 23.7400 39.6100 49.08%
2008 27.2946 26.8800 31.1400 20.7600 26.5700 -2.10%
2007 29.4235 26.3000 33.6900 25.2800 27.1400 4.26%
2006 26.9708 32.9400 34.7600 21.4200 26.0300 -19.93%
2005 32.0740 31.9000 36.6100 28.1100 32.5100 -0.91%
2004 34.8206 45.3400 49.1100 24.7000 32.8100 -28.67%
2003 37.1344 28.6600 48.8000 27.0200 46.0000 62.72%
2002 26.1297 31.0200 32.8100 18.6200 28.2700 -9.94%
2001 51.4740 48.3100 65.8500 27.8800 31.3900 -38.68%
2000 49.6670 35.0000 69.7200 33.8800 51.1900 42.95%
1999 40.0785 57.9400 59.1300 27.3100 35.8100 -43.05%
1998 44.5872 32.3100 62.8800 30.7500 62.8800 93.83%
1997 24.2175 22.3750 33.6250 16.3100 32.4400 44.37%
1996 19.6519 23.7800 24.6250 13.0000 22.4700 -8.29%
1995 18.2198 12.8750 24.7500 10.5000 24.5000 86.67%
1994 10.7638 11.7500 14.3750 6.5000 13.1250 3.96%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $61.270B $15.787B
Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $10.440B 4.25
Bausch Health Cos (BHC) Canada $10.337B 6.82
Mylan (MYL) United States $9.708B 4.35
Dr Reddy's Laboratories (RDY) India $6.778B 17.78
ASPEN PHARMACR (APNHY) South Africa $3.364B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.145B 11.08
Amphastar Pharmaceuticals (AMPH) United States $0.910B 47.27
Homology Medicines (FIXX) United States $0.877B 0.00
Voyager Therapeutics (VYGR) United States $0.499B 0.00
Assembly Biosciences (ASMB) United States $0.461B 0.00
Akorn (AKRX) United States $0.459B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.436B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.283B 0.39
Adamas Pharmaceuticals (ADMS) United States $0.174B 0.00
Sol-Gel Technologies (SLGL) Israel $0.163B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.130B 0.00
CymaBay Therapeutics (CBAY) United States $0.117B 0.00
Teligent (TLGT) United States $0.028B 0.00
China Pharma Holdings (CPHI) China $0.010B 0.00